The University of Southampton
University of Southampton Institutional Repository

A prospective observational cohort study comparing high-complexity against conventional pelvic exenteration surgery

A prospective observational cohort study comparing high-complexity against conventional pelvic exenteration surgery
A prospective observational cohort study comparing high-complexity against conventional pelvic exenteration surgery

Background: conventional pelvic exenteration (PE) comprises the removal of all or most central pelvic organs and is established in clinical practise. Previously, tumours involving bone or lateral sidewall structures were deemed inoperable due to associated morbidity, mortality, and poor oncological outcomes. Recently however high-complexity PE is increasingly described and is defined as encompassing conventional PE with the additional resection of bone or pelvic sidewall structures. This observational cohort study aimed to assess surgical outcomes, health-related quality of life (HrQoL), decision regret, and costs of high-complexity PE for more advanced tumours not treatable with conventional PE. 

Methods: high-complexity PE data were retrieved from a prospectively maintained quaternary database. The primary outcome was overall survival. Secondary outcomes were perioperative mortality, disease control, major morbidity, HrQoL, and health resource use. For cost-utility analysis, a no-PE group was extrapolated from the literature. 

Results: in total, 319 cases were included, with 64 conventional and 255 high-complexity PE, and the overall survival was equivalent, with medians of 10.5 and 9.8 years (p = 0.52), respectively. Local control (p = 0.30); 90-day mortality (0.0% vs. 1.2%, p = 1.00); R0-resection rate (87% vs. 83%, p = 0.08); 12-month HrQoL (p = 0.51); and decision regret (p = 0.90) were comparable. High-complexity PE significantly increased overall major morbidity (16% vs. 31%, p = 0.02); and perioperative costs (GBP 37,271 vs. GBP 45,733, p < 0.001). When modelled against no surgery, both groups appeared cost-effective with incremental cost-effectiveness ratios of GBP 2446 and GBP 5061. 

Conclusions: high-complexity PE is safe and feasible, offering comparable survival outcomes and HrQoL to conventional PE, but with greater morbidity and resource use. Despite this, it appears cost-effective when compared to no surgery and palliation.

cancer, health economics, high-complexity pelvic exenteration, morbidity, pelvic exenteration, quality of life, surgical oncology
2072-6694
West, Charles T.
f55ef5be-4040-4c3a-978e-d0ce1eaeb366
Tiwari, Abhinav
ac41bade-4864-42a9-aa6a-66b54449c930
Salem, Yousif
dfc6a232-7529-4bc0-865d-6ab3492284aa
Woyton, Michal
baeed9eb-117b-41f0-89bd-ec9fc99c8e5c
Alford, Natasha
40ef6950-d297-48a8-a80b-601e1e753d19
Roy, Shatabdi
8761bee7-4136-4a51-bd23-2c4bea3b3c6e
Russell, Samantha
8dd7bbe8-f759-4d58-afc7-9ad59b10936d
Ribeiro, Ines S
2fd1901b-61bd-4ad5-81b3-a3f8145ec144
Smith, Julian
ab0ccf7a-4360-4148-8eaa-04a65fd9cb1a
Yano, Hideaki
8295e4c5-7b60-4b0b-8542-ddce5ac5c38b
Cooper, Keith
ea064f58-d71d-404a-bcf3-49d243b8825b
West, Malcolm A
98b67e58-9875-4133-b236-8a10a0a12c04
Mirnezami, Alex H
b3c7aee7-46a4-404c-bfe3-f72388e0bc94
SCCET
West, Charles T.
f55ef5be-4040-4c3a-978e-d0ce1eaeb366
Tiwari, Abhinav
ac41bade-4864-42a9-aa6a-66b54449c930
Salem, Yousif
dfc6a232-7529-4bc0-865d-6ab3492284aa
Woyton, Michal
baeed9eb-117b-41f0-89bd-ec9fc99c8e5c
Alford, Natasha
40ef6950-d297-48a8-a80b-601e1e753d19
Roy, Shatabdi
8761bee7-4136-4a51-bd23-2c4bea3b3c6e
Russell, Samantha
8dd7bbe8-f759-4d58-afc7-9ad59b10936d
Ribeiro, Ines S
2fd1901b-61bd-4ad5-81b3-a3f8145ec144
Smith, Julian
ab0ccf7a-4360-4148-8eaa-04a65fd9cb1a
Yano, Hideaki
8295e4c5-7b60-4b0b-8542-ddce5ac5c38b
Cooper, Keith
ea064f58-d71d-404a-bcf3-49d243b8825b
West, Malcolm A
98b67e58-9875-4133-b236-8a10a0a12c04
Mirnezami, Alex H
b3c7aee7-46a4-404c-bfe3-f72388e0bc94

West, Charles T., Tiwari, Abhinav and Salem, Yousif , SCCET (2025) A prospective observational cohort study comparing high-complexity against conventional pelvic exenteration surgery. Cancers, 17 (1), [111]. (doi:10.3390/cancers17010111).

Record type: Article

Abstract

Background: conventional pelvic exenteration (PE) comprises the removal of all or most central pelvic organs and is established in clinical practise. Previously, tumours involving bone or lateral sidewall structures were deemed inoperable due to associated morbidity, mortality, and poor oncological outcomes. Recently however high-complexity PE is increasingly described and is defined as encompassing conventional PE with the additional resection of bone or pelvic sidewall structures. This observational cohort study aimed to assess surgical outcomes, health-related quality of life (HrQoL), decision regret, and costs of high-complexity PE for more advanced tumours not treatable with conventional PE. 

Methods: high-complexity PE data were retrieved from a prospectively maintained quaternary database. The primary outcome was overall survival. Secondary outcomes were perioperative mortality, disease control, major morbidity, HrQoL, and health resource use. For cost-utility analysis, a no-PE group was extrapolated from the literature. 

Results: in total, 319 cases were included, with 64 conventional and 255 high-complexity PE, and the overall survival was equivalent, with medians of 10.5 and 9.8 years (p = 0.52), respectively. Local control (p = 0.30); 90-day mortality (0.0% vs. 1.2%, p = 1.00); R0-resection rate (87% vs. 83%, p = 0.08); 12-month HrQoL (p = 0.51); and decision regret (p = 0.90) were comparable. High-complexity PE significantly increased overall major morbidity (16% vs. 31%, p = 0.02); and perioperative costs (GBP 37,271 vs. GBP 45,733, p < 0.001). When modelled against no surgery, both groups appeared cost-effective with incremental cost-effectiveness ratios of GBP 2446 and GBP 5061. 

Conclusions: high-complexity PE is safe and feasible, offering comparable survival outcomes and HrQoL to conventional PE, but with greater morbidity and resource use. Despite this, it appears cost-effective when compared to no surgery and palliation.

Text
cancers-17-00111 - Version of Record
Available under License Creative Commons Attribution.
Download (6MB)

More information

Accepted/In Press date: 24 December 2024
Published date: 1 January 2025
Keywords: cancer, health economics, high-complexity pelvic exenteration, morbidity, pelvic exenteration, quality of life, surgical oncology

Identifiers

Local EPrints ID: 498908
URI: http://eprints.soton.ac.uk/id/eprint/498908
ISSN: 2072-6694
PURE UUID: 38f60523-a590-4301-a85c-2a1670da14ca
ORCID for Ines S Ribeiro: ORCID iD orcid.org/0000-0001-8464-4513
ORCID for Keith Cooper: ORCID iD orcid.org/0000-0002-0318-7670
ORCID for Malcolm A West: ORCID iD orcid.org/0000-0002-0345-5356

Catalogue record

Date deposited: 04 Mar 2025 18:05
Last modified: 22 Aug 2025 02:29

Export record

Altmetrics

Contributors

Author: Charles T. West
Author: Abhinav Tiwari
Author: Yousif Salem
Author: Michal Woyton
Author: Natasha Alford
Author: Shatabdi Roy
Author: Samantha Russell
Author: Ines S Ribeiro ORCID iD
Author: Julian Smith
Author: Hideaki Yano
Author: Keith Cooper ORCID iD
Author: Malcolm A West ORCID iD
Corporate Author: SCCET

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×